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We previously showed that a slowly replicating, minimally pathogenic clone of simian immunodeficiency virus (SIV), SIVmneCl8, evolves
increased ability to replicate in T cells with the onset of AIDS in pig-tailed macaques. Moreover, molecular clones derived from late stages of
infection (SIVmne170 and SIVmne027) replicate to high levels in vivo compared to SIVmneCl8. Here, we investigated the role of rt mutations in
SIVmne variant replication. We demonstrate selection for rt alleles that enhance viral infectivity and replication capacity in CD4+ T cells.
Moreover, the ability of SIVmne to be induced from resting CD4+ T cells by anti-CD3/CD28 stimulation is more strongly influenced by the
variant rt alleles than nef alleles. Taken together, our data underscore the importance of RT determinants for pathogenicity of SIV and for the
capacity to replicate in CD4+ T cell populations.
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During the course of human immunodeficiency virus type 1
(HIV-1) infections, viral variants with distinct characteristics
emerge that may be important for persistence and disease
progression. Typically, these variants have greater ability to
infect and replicate in CD4+ T cells compared to the viruses
present at the early stages of infection, suggesting that
mutations evolve to enhance replicative capacity (reviewed in
Kimata, 2006). The level of HIV-1 replication in the host
heralds the onset of AIDS, which underscores the potential
importance of viral replicative capacity in driving disease
progression (Connor et al., 1993; Embretson et al., 1993; Ho et
al., 1989; Mellors et al., 1996, 1997; Pantaleo et al., 1993;
Schnittmen et al., 1990; Zhang et al., 1999). However, defining
the exact evolutionary changes in the virus that influence HIV-1
replication is difficult because of the absence of an animal⁎ Corresponding author. Fax: +1 713 798 4435.
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doi:10.1016/j.virol.2007.08.011model to evaluate HIV-1 replication, persistence, and disease.
Similar evolution of viral variants has been observed with
simian immunodeficiency virus (SIV), making it an important
model for identifying and examining mutations that enhance the
replicative capacity and pathogenesis of emerging variant
viruses (Kimata, 2006; Whetter et al., 1999).
We and others have previously shown that infection of pig-
tailed macaques (Macaca nemestrina) with a variant, SIVm-
neCl8, results in the emergence of viral variants that
demonstrate increased replicative capacity in CD4+ T cells,
cytopathicity, and pathogenicity (Kimata et al., 1999; Over-
baugh et al., 1991; Rudensey et al., 1995). Importantly,
phenotypic differences of the parental virus and variants are
mainly revealed by infection of primary cells rather than cell
lines, which efficiently propagate all the viruses. Like early
stage HIV-1 variants, SIVmneCl8 is macrophage-tropic, slowly
replicating in T cells and minimally cytopathic. By contrast, we
have shown that late-stage molecular variants with increased
pathogenicity, SIVmne027 and SIVmne170, demonstrate
increased replicative capacity in phytohemagglutinin (PHA)-
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(PBMCs) compared to the early virus, SIVmneCl8 (reviewed
in Kimata, 2006). Surprisingly, the ability to replicate in
dendritic cell (DC) T cell co-cultures was significantly different
between these late variant viruses (Kimata et al., 1998, 2004;
Kimata and Overbaugh, 1997). SIVmne027 replicates to high
levels in the DC–T cell co-cultures, whereas replication of
SIVmne170 is limited, similar to SIVmneCl8 (Kimata et al.,
2004). Interestingly, a pol determinant was found to contribute
to the enhanced infectivity of SIVmne027, but not SIVmne170
(Patel et al., 2002). Further characterization of the pol
determinant of SIVmne027 showed that it contributes not
only to increased infectivity, but also greater virus replication in
DC–T cell co-cultures (Kimata et al., 2004). Here, we further
examine the contributions of mutations in pol, focusing on rt
variants and the effects of rt alleles on viral infectivity and
replication in DC–T cell co-cultures and in CD4+ T cells
activated through CD3/CD28 engagement.
Results
Pol contributes to the replicative capacity of a highly
pathogenic SIVmne
Initially, to determine the contribution of pol to the increased
replication capacity of a variant virus that emerged late in
infection, we infected DC–T cell co-cultures with a chimeric
virus containing the pol region of SIVmne027 (included are
five amino acid differences in the rt sequence compared toFig. 1. Schematic of viruses. Parental viruses are shown in bold. Chimeric viruses are
Point mutations are indicated with a black horizontal line. Hatched areas ( ) indicate
infected macaques; these regions were cloned into the SIVmneCl8 background.SIVmneCl8: I73M, K412E, K434E, K466R and A486T) in the
SIVmneCl8 backbone (chimera 8/027pol, see Fig. 1) and
compared the level of replication with that of the parental
viruses SIVmneCl8 and SIVmne027. DC–T cell co-cultures
were used because HIV and SIV replication in CD4+ T cells is
more efficient in the presence of DCs (Cameron et al., 1992;
Gummuluru et al., 2002; Kimata et al., 2004; Messmer et al.,
2000; Pope et al., 1994).
A summary of the characteristics of the parental viruses
SIVmneCl8 (early variant virus) and SIVmne170 and SIVmne027
(late variant viruses) is shown in Table 1 with accompanying
references. The molecular cloning and initial in vitro phenotypic
characterizations of SIVmneCl8, SIVmne170 and SIVmne027
have been described in the indicated references. Each virus
was obtained by lambda-phage cloning of provirus (Kimata
et al., 1998; Kimata and Overbaugh, 1997). Although cloned
from a pig-tailed with lymphoma, SIVmneCl8 is phenotypi-
cally similar to variants found early after infection, whereas
SIVmne170 and SIVmne027 are representative of variants
found at later stages of infection following inoculation with
SIVmneCl8 (Kimata et al., 1998; Kimata and Overbaugh,
1997; Rudensey et al., 1995). SIVmne170 is derived from
PBMCs and SIVmne027 was cloned from lymph node tissue.
The in vivo pathogenicities of these viruses were previously
reported (Kimata et al., 1999).
As shown in Fig. 2A, the chimeric virus 8/027pol replicated
to a 60-fold higher level than the early parental virus,
SIVmneCl8. The replication level was similar to a control
chimeric virus, 8/027nef, which contains the nef allele fromshown with the corresponding regions of the parental viruses shaded accordingly.
regions cloned from viruses isolated 6 weeks post-infection from SIVmne170-
Table 1
Summary of in vivo and in vitro replication profiles of SIV variants
Virus type Name Plasma viral load a In vitro replication capacity References
Peak Set-point PHA-stimulated
lymphoblasts
Macrophages Dendritic
cells
Resting
CD4+
T cells
DC-T
cell
co-cultures
Early SIVmneCl8 1.4×107 2.4×103 Low Moderate NDb ND Low Kimata et al., 2004; Kimata and
Overbaugh, 1997; Patel et al., 2002;
Rudensey et al., 1995
Late (blood) SIVmne170 5.3×107 6.0×106 High Low ND ND Low Kimata et al., 1999, 2004; Kimata and
Overbaugh, 1997; Patel et al., 2002;
Rudensey et al., 1995
Late (lymph node) SIVmne027 4.2×108 8.3×106 High Low ND Low High Kimata et al., 1998, 1999; Patel et al.,
2002
a RNA copies per milliliter. Peak viral load for SIVmne170 is delayed by 2–3 weeks.
b ND, not detected.
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infectivity relative to SIVmneCl8 (Patel et al., 2002). Neither
determinant alone was sufficient to completely confer a
replication profile similar to that of SIVmne027.
The ability of the chimeric viruses to infect resting CD4+ T
cells and replicate after subsequent activation was then
measured and compared. As shown in Fig. 2B, replication of
8/027pol was high in response to anti-CD3/anti-CD28
costimulation, which mimics normal T cell stimulation and
activation. Replication was similar to SIVmne027 and nearly
100-fold greater than the parental virus, SIVmneCl8. By
contrast, the 8/027nef chimera failed to replicate efficiently and
produced 10- to 100-fold lower levels of p27 antigen than
SIVmneCl8. Together, these data suggest that the SIVmne027
pol region is an important determinant for increased viral
replication in T cells. Additionally, because the pol determinant
mainly consists of sequences from the rt gene, the data suggest
that differences in the rt gene may account for the enhanced
replication capacity of SIVmne027.
A connection domain mutation enhances replication of
SIVmneCl8
To identify specific amino acid residues of the variant-
specific rt alleles that could account for the minimal infectivity
of SIVmneCl8, we compared the proviral DNA sequences of
the SIVmne027 and SIVmneCl8 rt alleles with those of other
SIV clones. We identified two unique amino acid mutations, a
lysine at position 412 within the connection domain and an
alanine at 486, in the SIVmneCl8 rt gene (Fig. 3). Since both of
these amino acids occur only in the minimally pathogenic virus,
SIVmneCl8, and not in the more pathogenic viruses
SIVmne027 and SIVmne170 (both of which contain the
consensus glutamate and threonine at positions 412 and 486,
respectively) we examined the effects of these mutations on
infectivity and viral replication. Site-directed mutagenesis was
used to introduce either a single amino acid mutation in RT at
position 412 that changes the lysine to the consensus glutamic
acid (mutant Cl8-RTK412E) or position 486 that changes the
alanine to threonine in SIVmneCl8 (Fig. 3). Infectivity of the
two mutant viruses was tested in sMAGI cells and only the Cl8-RTK412E mutant demonstrated an increase in infectivity
relative to the parental virus, SIVmneCl8 (data not shown),
and therefore, was further characterized. Interestingly, the Cl8-
RTK412E mutant demonstrated a 12-fold increase in infectivity
compared to the parental virus SIVmneCl8 in the sMAGI assay.
This increase was similar to that of the 8/027pol chimera (Fig.
4A). Additionally, the Cl8-RTK412E mutant showed a 10-fold
enhanced replication in CD4+ T cells in response to anti-CD3/
anti-CD28 costimulation relative to the parental SIVmneCl8
virus (Fig. 4B). This was similar to the 8/027pol chimeric virus.
Together with the data in Fig. 2 these data indicate a role for
mutations in the connection domain of RT in influencing viral
infectivity and replication in CD4+ T cells.
Primary infection and RT infectivity
SIVmne170, like SIVmne027, is also a late stage clone, but
replication in DC–T cell co-cultures and infection of resting
PBMCs or T cells is significantly impaired compared to
SIVmne027 (Table 1) (Kimata et al., 1998, 2004; Patel et al.,
2002). Furthermore, when SIVmne170 was inoculated into
pig-tailed macaques, peak plasma viral loads were delayed by
2–3 weeks and nearly 10-fold lower than viral loads in
SIVmne027-infected animals, although set-point viral loads
were comparable for both viruses (Kimata et al., 1999). These
data suggest that SIVmne170 may undergo early selection for
mutations with increased replicative capacity. To identify
residues in the SIVmne170 rt gene that may confer its low
infectivity, variant rt alleles were cloned and sequenced from
PBMC specimens taken at 6 weeks post-infection of two pig-
tailed macaques infected with the molecular clone SIVmne170
(Kimata et al., 1999). Variant and parental rt allelic sequences
were compared. A single point mutation (I148V) was found to
be common to all of the variant alleles (Fig. 3). Mutant
chimeric viruses containing variant rt alleles in the background
of SIVmneCl8 were generated using previously described
methods (Patel et al., 2002). The infectivity of three re-
presentative clones (8/170pol6A containing the following rt
changes from the parental virus SIVmne170: I148V and
Q474P; 8/170pol6B containing the following rt changes from
the parental virus SIVmne170: I148V, R173G, P419S and
Fig. 2. Viral replication in T cells. (A) Replication of SIV variants in pig-tailed
macaque dendritic cell–T cell co-cultures. Monocyte-derived dendritic cells
were co-cultured with autologous T cells in triplicate and infected with chimeric
and parental viruses as described (Kimata et al., 2004). Viral replication was
monitored by measuring SIV p27 levels in supernatants of the co-cultures by
ELISA. (B) Replication of SIV variants in pig-tailed macaque CD4+ T cells
costimulated with anti-CD3/anti-CD28 antibodies. T cells were infected with
virus in triplicate, washed, and incubated in plates coated with anti-CD3 and
anti-CD28 for 24 h. Cultures were allowed to continue for 2 weeks. Supernatants
were harvested and media replaced every 3–4 days. In both panels A and B,
average p27 levels±SD are shown. Data are representative of six and two
independent experiments in panels A and B, respectively.
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from the parental virus SIVmne170: V108I, I148V, R173K,
G211S, F227L, I257M and T288A) was compared to the early
variant SIVmneCl8, the late variant SIVmne027 (both of
which contain valine at position 148) as well as a chimeric
virus containing the pol region of SIVmne170 in the backbone
of SIVmneCl8 (Fig. 5A). Constructing the chimeric viruses in
the SIVmneCl8 background enabled us to limit the effects on
infectivity to mutations contained only in the pol region and
‘normalized’ effects of other regions of the viral genome. All of
the pol chimeric viruses were similar to the chimeric virus 8/
027pol and showed 2- to 3-fold increases in infectivity
compared to either SIVmneCl8 or 8/170pol, suggesting that
the valine at 148 enhances viral infectivity. Interestingly, earlier
biochemical studies of RTs containing either isoleucine or
valine at position 148 have demonstrated that I148-containing
RT (found in SIVmne170) has lower dNTP binding affinitycompared to RT dNTP binding with a corresponding valine
(Diamond et al., 2003). This decrease in dNTP binding resulted
in an increase in replication fidelity in the SIVmne170 variant
(Diamond et al., 2001).
Since each of the tested chimeric viruses contained its own
unique set of mutations in addition to the I148V mutations, we
were unable to conclude that the I148V mutation in these
chimeras was solely responsible for the increased infectivity.
Therefore, to confirm the importance of the I148V RT mutation
in viral infection and replication, we introduced a valine at
position 148 of RT within SIVmne170 (170-RTI148V), and
compared the infectivity and replication capacity of the mutant
with SIVmneCl8, SIVmne027, and parental virus, SIVmne170.
In the sMAGI assay, infectivity of 170-RTI148V was similar to
SIVmne027 and 3- to 4-fold more infectious than SIVmne170
(Fig. 5B). In DC–T cell co-cultures, 170-RTI148V replicated to
a high level, similar to the variant SIVmne027, while the
replication level of the parental virus, SIVmne170 was less than
that of SIVmneCl8 (Fig. 5C). Furthermore, when resting CD4+
T cells were infected and then activated with anti-CD3/anti-
CD28 costimulation, 170-RTI148V replicated to significantly
higher levels than the parental virus, SIVmne170 (Fig. 5D).
Together, these data confirm that functionality of RT in SIV is a
significant determinant of viral infectivity, which impacts
infection and replication in CD4+ T cells.
Discussion
The capacity for HIV-1 and SIV to infect and spread through
the CD4+ T cell population is central to AIDS pathogenesis
(Haase, 2005). Both plasma viral load and CD4+ T cell de-
pletion are linked to the extent to which the infecting virus is
able to spread through the T cell population. Recent studies
suggest that the target cell population consists mainly of
memory CD4+ T cells that have resting phenotypes (Mattapallil
et al., 2005; Veazey et al., 2000). Also, we and others have
demonstrated that plasma viral load is a reflection of the
replicative capacity of the infecting SIV variant in primary
CD4+ T cells, but not macrophages or cell lines (Kimata et al.,
1999). Similar observations have been reported for HIV-1
infection (Campbell et al., 2003). Furthermore, RT mutations
that modulate viral replicative capacity of HIV-1 infection
influence plasma viral load, even in the absence of or prior to
antiretroviral therapy (Barbour et al., 2004; Daar et al., 2005).
Additionally, Nef has been shown to have a significant role in
increasing replication and spread of SIV through the CD4+ T
cell population (Mohri et al., 2001; Roeth and Collins, 2006).
Here, we present data indicating that RT mutations in SIV also
modulate viral infection and replicative capacity in CD4+ Tcells
and influence the contribution of Nef to viral replication.
We found that the pol region of a late stage variant
SIVmne027 was able to enhance viral replication in the
background of SIVmneCl8. When the chimeric virus 8/
027pol was compared with 8/027nef, it was observed that the
pol determinant played a more significant role in infectivity
and replication in resting CD4+ T cells than did nef. Thus, while
both determinants enable replication in DC–T cell co-cultures,
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CD4+ T cells in response to costimulation via CD3/CD28.
Because an earlier study did not identify a functional defect in
the enzymatic activity of the SIVmneCl8 RT (Diamond et al.,
2003), we focused our further analysis on the unique
SIVmneCl8 mutation within the connection domain of RT.
An introduction of a single mutation in the connection domain,Fig. 3. Predicted amino acid sequences of RT variants. Variant reverse transcriptase a
weeks post-infection were sequenced and the amino acid sequences were determined.
with 233-6 were from macaque J94233. The infection of these animals with SIVm
170pol6A, 8/170pol6B, and 8/170pol6C, that were used for infectivity studies in
respectively, in the background of SIVmneCl8; restriction enzyme sites for the reco
were constructed as described in the Materials and methods (Patel et al., 2002). TheK412E, of the SIVmneCl8 RTwas able to enhance infectivity of
SIVmneCl8 to levels comparable to the chimeric virus 8/
027pol. Mutations in the HIV-1 RT connection domain are
known to affect polymerization, RNase H activity, dimerization
of the large (p66) and small (p51) RT subunits and inhibit RT
activity (Argyris et al., 1999; Cen et al., 2004; Divita et al.,
1994; Julias et al., 2003; Nikolenko et al., 2007), therefore, it islleles cloned from PBMC DNA of SIVmne170-infected pig-tailed macaques at 6
Sequences labeled 393-6 were derived from macaque F94393 and those labeled
ne170 was previously reported (Kimata et al., 1999). Recombinant viruses, 8/
Fig. 5A include the variant rt alleles from 393-6.13, 233-6.22, and 233-6.28,
mbinants lie outside of the region presented in this figure. Recombinant viruses
connection domain of RT is highlighted in gray.
Fig. 4. Infectivity and replication of Cl8-RTK412E. (A) The infectivity of RT
mutant, Cl8-RTK412E, was compared to the parental virus, SIVmneCl8, and
chimeric virus 8/027pol using the sMAGI infectivity assay as described (Patel et
al., 2002). Infections were carried out in triplicate. The average numbers of
infected cells per nanogram p27±SD are shown. One representative of four
independent experiments is shown. (B) Replication of the mutant Cl8-RTK412E
in pig-tailed macaque CD4+ T cells after costimulation with anti-CD3/anti-
CD28 monoclonal antibodies. The average p27 levels±SD are shown and the
data are representative of independent experiments using cells from two
different pig-tailed macaque donors.
Fig. 3 (continued).
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SIVmneCl8 also affects dimerization of the two RT subunits,
flexibility of the protein or binding affinity for an unknown
cellular co-factor necessary for efficient reverse transcription.
Next, we demonstrated that an RT mutation dramatically
enhances replicative capacity of another SIV variant,
SIVmne170, in DC–T cell co-cultures and in resting CD4+ T
cells following costimulation. Previous studies found that while
SIVmne170 could replicate efficiently in cell lines and PHA-
stimulated PBMCs, it fails to replicate in DC–T cell co-cultures
and resting PBMC cultures (Kimata et al., 1998, 1999; Kimata
and Overbaugh, 1997). Here, when we infected resting CD4+ T
cells, this virus did not replicate in response to costimulation.
This phenotype occurred despite the fact that SIVmne170
encodes a functional Nef protein that enhances infectivity (Patel
et al., 2002). Interestingly, unlike the variant SIVmne027,
which replicates efficiently in DC–T cell co-cultures and in
resting CD4+ T cells in response to costimulation, SIVmne170
does not encode an rt allelic determinant that increases viral
infectivity (Patel et al., 2002). These data suggest that the rt
gene modulates replication in CD4+ T cells.
We defined a single mutation from isoleucine to valine at
position 148 (I148V) of RT in SIVmne170 that was able to
enhance both infectivity and replication levels of SIVmne170 to
levels comparable to SIVmne027 in both DC–T cell co-cultures
and in resting CD4+ T cells in response to activation signals. We
also found that valine 148 is rapidly selected during primary
infection of SIVmne170-infected macaques. Interestingly, it
was demonstrated earlier that the SIVmne170 RT has lower
dNTP binding affinity than other SIV RTs due to the isoleucine
at 148, and conversion to the consensus valine increases dNTP
binding affinity (Diamond et al., 2003). That the valine at 148 is
critical for high dNTP binding affinity, infectivity and
replication suggests its importance for infection of T cells,
particularly resting CD4+ T cells which have lower levels of
dNTPs compared to activated T cells (Diamond et al., 2004).
Moreover, as we observed with the SIVmneCl8/SIVmne027
Fig. 5. Infectivity and replication of SIV mutants. (A) RT clones recovered from SIVmne170-infected macaques were sequenced and compared (see Fig. 3). RT coding
sequences of three representative isolates were placed into the SIVmneCl8 background and the influence of the mutations on infectivity of the chimeric viruses
(8/170pol6A, 8/170pol6B, and 8/170pol6C) was examined using the sMAGI infectivity assay. The average numbers of infected cells per nanogram p27±SD are
shown. One representative of two independent experiments is shown. (B) Infectivity of a SIVmne170 mutant containing a valine at position 148 of RT (170-RTI148V)
was compared to the infectivity of the early virus, SIVmneCl8, late variant SIVmne027, and the isogenic parental virus, SIVmne170 using the sMAGI infectivity
assay. The average numbers of infected cells per nanogram p27±SD are shown. One representative of three independent experiments is shown. (C) Replication of the
mutant, 170-RTI148V, in pig-tailed macaque DC–T cell co-cultures. (D) Replication of the mutant 170-RTI148V in pig-tailed macaque CD4+ T cells after
costimulation with anti-CD3/anti-CD28 monoclonal antibodies. In C and D, the average p27 levels±SD are shown and the data are representative of two independent
experiments using cells from two different pig-tailed macaque donors.
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Nef asserted a pronounced negative effect on SIVmne170
replication in CD4+ T cells or if the virus could overcome the
effect and replicate. These results suggest that RT mutations that
increase dNTP binding affinity enable SIV, and by analogy
HIV-1, to exploit and replicate in cellular environments that
otherwise would be unfavorable for viral replication. Interest-
ingly, competitive replication assays using SIVmne variants
also demonstrate that a key determinant of viral replication
fitness is located in the 5′ half of the viral genome (Voronin et
al., 2005), which when considered with our results implicates
the pol domain or, more specifically, the rt sequence of the viral
genome as an important replication determinant.
A number of functions have been ascribed to Nef that may
have a role in HIV-1 or SIV replication, including down-
regulation of CD4, major histocompatibility complex I, CD3,
and CD28, and modulation of viral infectivity and T cell
activation (reviewed in Roeth and Collins, 2006). In earlier
studies, we and others showed that the parental virusSIVmneCl8 encodes a nef allele with minimal activity. As
this virus evolves in vivo, it acquires mutations in nef that
primarily increase viral infectivity and enable CD4 down-
regulation (Heidecker et al., 1998; Patel et al., 2002). The
SIVmne170 and SIVmne027 nef alleles are representative of
variants that have acquired these activities. Whether the
mutations in these nef variants also affect CD3/CD28 down-
regulation, thereby interfering with T cell activation is
unknown, but should be further investigated as a potential
explanation for the inhibitory effect these alleles have on viral
replication in resting CD4+ T cells after activation via CD3/
CD28. Interestingly, in DC–T cell co-cultures, we found that
the inhibitory effect of Nef in context of low functioning RTs is
not observed, suggesting that activation signals derived from
DC–T cell interactions and which increase viral replication may
occur through molecules other than CD3 and CD28, bypassing
the negative effects of Nef. Alternatively, DC infection may
induce cytokines and chemokines that render T cells permissive
for viral infection.
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infectivity and replication determinant. The data provide further
evidence that the pathogenicity of SIV may be linked to its
capacity to spread in the CD4+ T cell population. Whether
mutations in RT allow infection of specific T cell populations
based on the activation status of the T cells needs to be explored
further. This is significant in light of the discovery that the
primary targets during early stages of HIV infection are memory
CD4+ T cells with a ‘resting’ phenotype (Haase, 2005; Li et al.,
2005; Zhang et al., 1999). While it may be argued that the
SIVmneCl8 RT variant studied here resulted from happenstance
and is unlikely to predominate at any time during infection of
the host, the SIVmneCl8 genotype has been shown to
predominate in primary infection following intrarectal inocula-
tion of an uncloned population of SIVmne variants (Polacino et
al., 1999). Additionally, SIVmneCl8 replicates as well as late
variants, SIVmne170 and SIVmne027, in cell lines and to a
higher level in monocyte-derived macrophages (Kimata et al.,
2004). These data suggest that SIVmneCl8 is not inherently
defective or unfit. Further, it is important to again note that post-
acute viral burden in the host has been correlated with
replicative capacity of RT variants (Campbell et al., 2003).
Thus, RT variants of different functional capacity may influence
viral replication and disease.
Materials and methods
Cell lines
The hybrid T cell–B cell line, CEMx174 (Russell et al.,
1985), was cultured in RPMI supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 100 U/ml penicillin,
100 μg/ml streptomycin and 2 mM L-glutamine. The indicator
cell line, sMAGI (Chackerian et al., 1995), was cultured in
RPMI medium supplemented with 0.2 mg/ml G418 and
50 U/ml Hygromycin B (sMAGI medium). 293 T Cells
(Lebkowski et al., 1985) were cultured in DMEM supplemented
with 10% heat-inactivated FBS, 100 U/ml penicillin, 100 μg/ml
streptomycin and 2 mM L-glutamine (DMEM medium). All
cultures were incubated in 37 °C/5% CO2 incubators.
Viruses
Chimeric viruses that contain either the pol region (8/
027pol) or nef gene (8/027nef) of SIVmne027 in the back-
ground of SIVmneCl8 or pol region of SIVmne170 in the
background of SIVmneCl8 (8/170pol) were previously
described (Kimata et al., 2004; Kimata and Overbaugh,
1997). Recombinant viruses 8/170pol6A, 8/170pol6B and 8/
170pol6C were constructed by excising a NsiI (position 1886)–
HpaI (position 3868) pol fragment from SIVmneCl8 and
replacing it with the homologous PCR-amplified variant pol
sequences from animals infected with SIVmne170.
Stocks of SIVmneCl8, SIVmne027, SIVmne170, and
chimeric viruses were generated by transfection of 293 T cells
with cloned proviral sequences using the FuGENE 6 transfec-
tion kit (Invitrogen) according to the manufacturer's instruc-tions. The cultures were incubated for 48 h post-transfection, at
which time supernatant was harvested and passed through 0.22-
μm filters. Viral supernatants were titered on sMAGI cells and
either frozen at −80 °C until needed or were then mixed with
CEMx174 cells to amplify the viral stocks. Supernatants from
CEMx174 cells were collected on days 7, 10 and 12 days post-
infection, passed through 0.22-μm filters, titered on sMAGI
cells and the highest titer viral supernatants were stored at
−80 °C until use.
PCR Cloning of pol fragments
Pig-tailed macaque genomic DNA specimens from PBMCs
isolated at 6 weeks after inoculation with the molecular clone
SIVmne170 were kindly provided by Julie Overbaugh (Fred
Hutchinson Cancer Research Center) (Kimata et al., 1999). The
virus stock of SIVmne170 used for infection was produced by
transfecting CEMx174 cells and passaging 7 days. The proviral
load in each DNA specimen was determined by quantitative
real-time PCR essentially as described (Williams and Over-
baugh, 2004). A volume of DNA sample estimated to contain
one SIV genome was used to amplify and clone individual pol
sequences by nested PCR. Pol sequences were amplified using
TaqPlus long polymerase mixture (Stratagene, La Jolla, CA) to
minimize mutations due to PCR. The first round PCR directly
amplified pol from the genomic DNA sample. Two microliters
of the first round PCR was used for amplification in the second
round. Round-one primers Pr-RT1 (5′-GACACTCTGCAAGG-
CAATGCAGAGC-3′, 1731–1756) and Pr-RT4 (5′-ATACC-
TTTGTGTGCTGGCACCCATGC-3′, 3916–3941) amplified a
2.2-kb fragment. Round-two primers Pr-RT2 (5′-CAAGAA-
GACAGGGCTGCTGGAAATG-3′, 1758–1783) and Pr-RT3
(5′-ATTTGGTTAACTAGCCTGCTCTCTG-3′, 3854–3880)
amplified a 2.1-kb fragment. Reactions were performed using
the following mixtures in 50 μl: 1× TaqPlus long buffer, 800 nM
dNTPs, 200 ng of each primer, and 1.5 U TaqPlus long
polymerase. For both rounds 1 and 2, amplification was
initiated with denaturation at 94 °C for 5 min followed by 35
cycles of amplification (denaturation at 94 °C for 30 s,
annealing at 56 °C for 30 s and a final extension at 72 °C for
2 min). Amplified products were cloned into a TOPO cloning
vector (Invitrogen) and the sequences were determined.
Site-directed mutagenesis
Specific mutations were introduced into rt gene sequences
by QuikChange mutagenesis according to the manufacturer's
protocol (Stratagene, La Jolla, CA). Subclones of SIVmneCl8
or SIVmne170 that contained gag-pol sequences inserted into
pBluescript KS+ were used for mutagenesis. To introduce a
mutation in the SIVmneCl8 rt gene that would change lysine at
amino acid position 412 to glutamate, primers 5′-GGTAACC-
TGGATACCGGAATGGGATTTTATCTCAAC-3′ and 5′-
GTTGAGATAAAATCCCATTCCGGTATCCAGGTTACC-3′
were used. To introduce a mutation in the SIVmneCl8 rt gene
that would change alanine at position 486 to threonine, primers
5′-CATTTCTCATGGCATTGACAGACTCAGGGCCAAAG-
192 T. Biesinger et al. / Virology 370 (2008) 184–1933′ and 5′-CTTTGGCCCTGAGTCTGTCAATGCCATGA-
GAAATG-3′ were used for mutagenesis. To introduce a
mutation in the SIVmne170 rt gene that would change the
isoleucine at position 148 to valine, primers 5′-AAACGATA-
CATTTATAAGGTTCTGCCTCAGGGGTGG-3′ and 5′-
CCACCCCTGAGGCAGAACCTTATAAATGTATCGTTT-3′
were used for mutagenesis. Mutations were confirmed by auto-
mated DNA sequencing and NsiI–HpaI fragments were cloned
into the background of the respective isogenic parental provirus,
either SIVmneCl8 or SIVmne170.
sMAGI assay
Infection of sMAGI indicator cells was performed as
described (Chackerian et al., 1995). Infectivity was determined
by averaging the number of blue (infected) cells in triplicate
cultures, subtracting the average number of blue cells in the
uninfected control cultures and dividing by the volume of input
viral supernatant. sMAGI assays were performed with different
viral stocks for each experiment.
Dendritic cell/CD4+ T cell infection
Peripheral blood mononuclear cells (PBMCs) were purified
from pig-tailed macaque blood by Ficoll centrifugation as
described previously (Kimata et al., 2004). To generate
monocyte-derived DCs, CD14+ monocytes were isolated
using Miltenyi anti-CD14 microbeads and miniMACS system
according to the manufacturer's protocol (Miltenyi Biotec,
Auburn, CA). Monocytes were cultured in RPMI medium
supplemented with 1000 U/ml granulocyte macrophage colony-
stimulating factor (GM-CSF) and 1000 U/ml interleukin-4 (IL-
4) for 1 week to induce maturation to dendritic cells as
described (Yu Kimata et al., 2002). Dendritic cells were then co-
cultured with autologous CD4+ T cells. Co-cultures were
incubated with equal amounts of infectious virus (MOI=0.01),
as determined by sMAGI assay, for 3 h and then cells were
washed to remove excess virus and reseeded in RPMI medium.
Cultures were continued for 2–3 weeks with supernatant
samples collected and media replaced every 3–4 days post-
infection. Supernatant SIV p27 levels were measured by ELISA
(Beckman Coulter, Fullerton, CA). Cells used in duplicate
experiments were from different pig-tailed macaque blood
samples.
Resting CD4+ T cell infection and activation
PBMCs were purified from pig-tailed macaque blood by
Ficoll centrifugation as described previously (Kimata et al.,
2004). CD4+ T cells were purified by negative selection using
a non-human primate CD4+ T cell isolation kit (Miltenyi
Biotec Inc.) according to the manufacturer's instructions.
CD4+ T cells were 90% pure by flow cytometry analysis. After
isolation, CD4+ T cells (5×105) were immediately incubated
with equal amounts of infectious virus (MOI=0.1), as
determined by sMAGI assay, for 3 h in 2 ml RPMI. Cells
were washed twice with RPMI to remove unbound virus,resuspended in 2 ml RPMI and incubated for 24 h. T cells were
then transferred to RPMI media +50 U/ml of interleukin-2 (IL-
2) and 24-well plates coated with 1 μg/well of both anti-CD3
and anti-CD28 antibodies. Cultures were incubated for 2
weeks, supernatant samples were taken and media replaced
(RPMI+IL-2) every 2 days. Supernatant SIV p27 levels were
measured by ELISA (Beckman Coulter, Fullerton, CA). Cells
used in duplicate experiments were from different pig-tailed
macaque blood samples.
Nucleotide sequence accession numbers
Variant pol sequences cloned from SIVmne170-infected
macaques were deposited into GenBank (accession numbers
EF028382-EF028389).
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